AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- 0 vs. Q4 2024
- Shares held
- 14.3M
- −188.1K (−1.3%) vs. Q4 2024
- Total value
- $19.5M
- −$546.4K (−2.7%) vs. Q4 2024
- New holders
- 5
- 8 more added
- Sold out
- 5
- 11 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 49 | $67 | 0.00% | −3−5.8% | Reduced |
| SBI Securities Co., Ltd. | 200 | $272 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 300 | $408 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 300 | $408 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 312 | $424 | 0.00% | 00.0% | Unchanged |
| Coldstream Capital Management Inc | 783 | $1.06K | 0.00% | +783 | New |
| Innovative Advisory Group, LLC | 1,170 | $1.59K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,082 | $2.83K | 0.00% | +619+42.3% | Added |
| Captrust Financial Advisors | 10,000 | $13.6K | 0.00% | −18,667−65.1% | Reduced |
| Qube Research & Technologies Ltd | 10,184 | $13.8K | 0.00% | −10.0% | Reduced |
| Federated Hermes, Inc. | 12,237 | $16.6K | 0.00% | +4,745+63.3% | Added |
| Jane Street Group, LLC | 18,131 | $24.7K | 0.00% | +18,131 | New |
| Inspirion Wealth Advisors, LLC | 18,950 | $25.8K | 0.00% | +18,950 | New |
| Schonfeld Strategic Advisors LLC | 20,115 | $27.4K | 0.00% | −6,785−25.2% | Reduced |
| Private Advisor Group, LLC | 22,500 | $30.6K | 0.00% | 00.0% | Unchanged |
| Lepercq De Neuflize Asset Management LLC | 23,234 | $31.6K | 0.03% | +23,234 | New |
| Integrated Wealth Concepts LLC | 25,000 | $34.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 43,196 | $58.7K | 0.00% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 50,000 | $68.0K | 0.08% | +50,000 | New |
| Millennium Management LLC | 50,038 | $68.1K | 0.00% | −159,328−76.1% | Reduced |
| Bridgeway Capital Management, LLC | 59,900 | $81.5K | 0.00% | −102,300−63.1% | Reduced |
| State Street Corp | 87,002 | $118.3K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 106,021 | $144.2K | 0.00% | −64,271−37.7% | Reduced |
| Geode Capital Management, LLC | 253,923 | $345.4K | 0.00% | +26,127+11.5% | Added |
| BlackRock, Inc. | 300,686 | $408.9K | 0.00% | −735−0.2% | Reduced |
| Two Sigma Investments, LP | 343,960 | $467.8K | 0.00% | −56,372−14.1% | Reduced |
| Renaissance Technologies LLC | 368,708 | $501.4K | 0.00% | −211,065−36.4% | Reduced |
| Bank of America Corp | 385,483 | $524.3K | 0.00% | +80.0% | Added |
| Aldebaran Capital, LLC | 406,623 | $553.0K | 0.52% | +62,939+18.3% | Added |
| Bank of Montreal | 422,077 | $574.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 445,004 | $605.2K | 0.00% | −83,296−15.8% | Reduced |
| Bank of Nova Scotia | 459,194 | $624.5K | 0.00% | +64,326+16.3% | Added |
| Peapod Lane Capital LLC | 580,853 | $790.0K | 0.89% | +2,028+0.4% | Added |
| Pfizer Inc | 715,295 | $972.8K | 0.19% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $1.36M | 0.00% | +687,385+219.9% | Added |
| Vanguard Group Inc | 1,035,947 | $1.41M | 0.00% | 00.0% | Unchanged |
| Almitas Capital LLC | 1,313,111 | $1.79M | 0.59% | 00.0% | Unchanged |
| BML Capital Management, LLC | 5,749,432 | $7.82M | 6.33% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −196,732−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −83,206−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −67,994−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −62,441−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −34,179−100.0% | Sold out |